EW Articles, Edwards Lifesciences Corporation - From 11/15/23

Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 10 years by 10.52% on an annualized basis producing an average annual retu...

On CNBC’s "Mad Money Lightning Round," Jim Cramer said The Trade Desk, Inc. (NASDAQ: TTD) is an "expensive stock, but it is ...

Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 10.72% on an annualized basis producing an average annual retu...

The third-quarter earnings season has largely been mixed so far, reflecting the impact of the economic uncertainties on profit growth. That said, d...

It’s a day of risk aversion on Wall Street as investors are shedding both stocks and bonds in favor of cash while digesting the latest corpor...

Mixed earnings have dampened the market’s risk appetite, as indicated by U.S. stock futures, which suggest a mixed opening on Wednesday. The ...

After the first week of earnings, analysts have tempered their expectations for profit growth, anticipating a continuation of the profit-decli...

Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years by 9.2% on an annualized basis producing an average annual return...

U.S. medical devices manufacturer Edwards Lifesciences Corp (NYSE: EW) is reportedly under the scrutiny of EU antitrust regulators for it...

In the current market session, Edwards Lifesciences Inc. (NYSE:EW) price is at $71.15, after a 0.01% spike. However, over the past month, the stock...